Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 12 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-07 Cohen Yuval Chief Executive Officer Sale 10b5-1 −17,000 $10.08 $171K 157,316
2026-02-13 Cohen Yuval Chief Executive Officer Sale 10b5-1 −13,871 $7.78 $108K 174,316
2026-01-14 Cohen Yuval Chief Executive Officer Grant or award +50,000 188,187
2026-01-14 Cohen Yuval Chief Executive Officer Grant or award · Stock options (right to buy) +150,000 150,000
2025-10-27 Cohen Yuval Chief Executive Officer Exercise or conversion 10b5-1 +8,973 $4.26 $38K 147,160
2025-10-27 Cohen Yuval Chief Executive Officer Sale 10b5-1 −8,973 $17.14 $154K 138,187
2025-10-27 Cohen Yuval Chief Executive Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −8,973 22,106
2025-10-24 Cohen Yuval Chief Executive Officer Exercise or conversion 10b5-1 +18,660 $4.26 $79K 156,847
2025-10-24 Cohen Yuval Chief Executive Officer Sale 10b5-1 −18,660 $17.01 $317K 138,187
2025-10-24 Cohen Yuval Chief Executive Officer Exercise or conversion · Stock options (right to buy) 10b5-1 −18,660 31,079
2025-02-14 Cohen Yuval Chief Executive Officer Sale 10b5-1 −7,134 $8.76 $62K 138,187
2025-01-31 Cohen Yuval Chief Executive Officer Grant or award +68,100 145,321
2025-01-31 Cohen Yuval Chief Executive Officer Grant or award · Stock options (right to buy) +228,800 228,800
2024-06-18 Cohen Yuval Chief Executive Officer Exercise or conversion 10b5-1 +11,667 $30.00 $350K 96,067
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −11,667 $42.24 $493K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Exercise or conversion 10b5-1 +1,770 $14.10 $25K 86,170
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −1,770 $42.24 $75K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Exercise or conversion 10b5-1 +2,322 $4.26 $10K 86,722
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −2,322 $42.24 $98K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −7,179 $42.24 $303K 77,221

Page 1 of 4 · 79 trades